HealthEquity
S&P 400
$96.26
+1.81%
Delayed · cached 15 min
Peer comparison
| Company | Price↕ | Market Cap↕ | P/E↕ | P/B↕ | ROE %↕ | ROCE %↕ | Div yield %↕ | Valuation |
|---|---|---|---|---|---|---|---|---|
| UnitedHealth Group | $ 379.09 | $340.27B | 24.39 | 3.48 | 36.51 | 9.73 | 2.31 | Above FV |
| Elevance Health | $ 418.72 | $90.81B | 18.52 | 2.02 | 12.62 | 8.43 | 1.65 | Above FV |
| Humana | $ 409.80 | $49.21B | 38.77 | 2.56 | 6.39 | 6.95 | 0.88 | Above FV |
| Centene Corporation | $ 66.42 | $32.81B | -4.91 | 1.45 | -29.58 | -16.46 | 0.00 | — |
| Molina Healthcare | $ 204.23 | $10.66B | 1,276.44 | 2.55 | 11.32 | 9.05 | 0.00 | Above FV |
| HealthEquity | $ 96.26 | $7.96B | 34.75 | 4.01 | 10.81 | 10.35 | 0.00 | Above FV |
Price, market cap, P/E, P/B and dividend yield reflect the live quote (delayed, cached 15 min); ROE/ROCE from reported financials. The highlighted row is the current company. Click a column header to sort. Educational data only.
How to read the peer comparison
This table places the company beside others in the same industry on a few common measures. Comparison adds context that a single company's numbers cannot give on their own.
- Valuation multiples like P/E and P/B are most meaningful within the same industry, because different industries naturally trade at different levels. Comparing a company only to its peers is more useful than to the whole market.
- Return measures (ROE, ROCE) show how efficiently each company turns capital into profit. A company well ahead of or behind its peers here is worth understanding.
- No single column decides anything. A beginner reads the row across — valuation, returns, and size together — and treats the highlighted current company as one data point among its peers.
- Use the sortable headers to rank peers on any measure, but remember that "cheaper" or "higher" on one metric is a starting question, not an answer.
Educational only — not a recommendation to buy, sell, or hold any security.